...
首页> 外文期刊>Radiation oncology >Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis
【24h】

Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis

机译:鼻咽癌调强放射治疗的回顾性剂量学研究:测量指导剂量的重建和分析

获取原文
           

摘要

Conventional phantom-based planar dosimetry (2D-PBD) quality assurance (QA) using gamma pass rate (GP (%)) is inadequate to reflect clinically relevant dose error in intensity-modulated radiation therapy (IMRT), owing to a lack of information regarding patient anatomy and volumetric dose distribution. This study aimed to evaluate the dose distribution accuracy of IMRT delivery for nasopharyngeal carcinoma (NPC), which passed the 2D-PBD verification, using a measurement-guided 3D dose reconstruction (3D-MGR) method. Radiation treatment plans of 30 NPC cases and their pre-treatment 2D-PBD data were analyzed. 3D dose distribution was reconstructed on patient computed tomography (CT) images using the 3DVH software and compared to the treatment plans. Global and organ-specific dose GP (%), and dose-volume histogram (DVH) deviation of each structure was evaluated. Interdependency between GP (%) and the deviation of the volumetric dose was studied through correlation analysis. The 3D-MGR achieved global GP (%) similar to conventional 2D-PBD in the same criteria. However, structure-specific GP (%) significantly decreased under stricter criteria, including the planning target volume (PTV). The average deviation of all inspected dose volumes (DV) and volumetric dose (VD) parameters ranged from ??2.93% to 1.17%, with the largest negative deviation in V100% of the PTVnx of ??15.66% and positive deviation in D1cc of the spinal cord of 6.66%. There was no significant correlation between global GP (%) of 2D-PBD or 3D-MGR and the deviation of the most volumetric dosimetry parameters (DV or VD), when the Pearson’s coefficient value of 0.8 was used for correlation evaluation. Even upon passing the pre-treatment phantom based dosimetric QA, there could still be risk of dose error like under-dose in PTVnx and overdose in critical structures. Measurement-guided 3D volumetric dosimetry QA is recommended as the more clinically efficient verification for the complicated NPC IMRT.
机译:由于缺乏信息,使用伽玛通过率(GP(%))的常规基于幻影的平面剂量法(2D-PBD)质量保证(QA)不足以反映强度调制放射治疗(IMRT)中临床相关的剂量误差关于患者的解剖结构和体积剂量分布。这项研究旨在评估通过测量指导的3D剂量重建(3D-MGR)方法通过2D-PBD验证的IMRT鼻咽癌(NPC)的剂量分布准确性。分析了30例NPC的放射治疗计划及其治疗前的2D-PBD数据。使用3DVH软件在患者计算机断层扫描(CT)图像上重建3D剂量分布,并将其与治疗计划进行比较。评估每个结构的总体剂量和器官特异性剂量GP(%)以及剂量-体积直方图(DVH)偏差。通过相关分析研究了GP(%)与体积剂量偏差之间的相互依赖性。在相同条件下,3D-MGR达到了与常规2D-PBD相似的总体GP(%)。但是,在更严格的标准下,包括规划目标体积(PTV),特定于结构的GP(%)显着降低。所有检查的剂量体积(DV)和体积剂量(VD)参数的平均偏差范围为2.93%至1.17%,其中PTVnx的V100%的最大负偏差为15.66%,而D1cc的D1cc的正偏差最大。脊髓占6.66%。当Pearson系数值为0.8进行相关性评估时,2D-PBD或3D-MGR的总体GP(%)与大多数体积剂量参数(DV或VD)的偏差之间没有显着相关性。即使通过基于幻像的预处理剂量学质量保证,仍可能存在剂量错误的风险,例如PTVnx中的剂量不足和关键结构中的剂量过量。建议使用以测量为指导的3D体积剂量法QA,以对复杂的NPC IMRT进行更有效的临床验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号